跳至主要内容
临床试验/CTRI/2020/06/025818
CTRI/2020/06/025818尚未招募未知

Efficacy and safety of combination of cholecalciferol and Curcuma longa as an add-on therapy to standard R-CHOP in Diffuse Large Bcell Lymphoma (DLBCL) - a randomized open label 2x2 factorial trial - E-SCHOLAR

JIPMER Intramural fund0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed patients of diffuse large B cell lymphoma (DLBCL) [based on the 2008 World Health Organization classification] to be started on R-CHOP with serum 25 hydroxy D level less than

排除标准

  • Subjects previously treated with chemotherapy except for prefix chemotherapy, radiotherapy, immunotherapy or experimental therapies for lymphoma or other malignancy.
  • History of other cancer within the past 5 years except curatively treated non- melanoma skin cancer or in situ carcinoma of
  • uterine cervix.
  • Subjects diagnosed with double hit or triple
  • hit lymphoma.

研究者

发起方
JIPMER Intramural fund

相似试验